Ikris Pharma
About Us Named Patient Program
Cities We Serve Contact Us
Albuvirtide

Sourced directly from the authorized manufacturer network to ensure authenticity and quality.

Ready to proceed? Order Albuvirtide on our secure patient portal to submit your prescription, upload documents and track your approval status.

Albuvirtide

Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.

Medicine Name: Albuvirtide
Generic Name (API): Albuvirtide
Dosage Form & Strength: 160 mg
Route: Intravenous (IV) infusion
Drug Class: Long-acting HIV-1 fusion inhibitor (albumin-binding gp41 peptide)

Manufacturer / Innovator:

Frontier Biotechnologies Inc. (前沿生物药业(南京)股份有限公司)

Regulatory Approval:

  • NMPA (China)
Family enjoying life with Named Patient Program access

Your Trustworthy Partner For Named Patient Program

  • your trusted partner for named patient program

    Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.

  • 100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.

    100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.

  • Medicines sourced from authorized manufacturers with full batch traceability

    Medicines sourced from authorized manufacturers with full batch traceability.

  • EU-GDP Compliant Warehousing for secure, quality-controlled global distribution.

    EU-GDP compliant warehousing for secure, quality-controlled global distribution.

  • Temperature-Controlled Logistics for Safe and Timely Delivery

    Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.

GDP Compliant View Certificate
Licensed Wholesale distributor View Certificate

What Is Albuvirtide Used For?

Albuvirtide is a long-acting HIV medicine given by a weekly drip into a vein. It was discovered and developed in China by Frontier Biotechnologies of Nanjing, and is sold there under the brand name 艾可宁® (Aikening). The company describes it as the first long-acting HIV-1 fusion inhibitor to be approved anywhere.

China's drug regulator (then the CFDA, now the NMPA) approved it in 2018 for:

  • HIV-1 infection in people who have already taken antiretroviral treatment but whose virus is still multiplying
  • Always used together with other HIV medicines, never on its own

It sits within our infections and specialty medicines range and should be prescribed and supervised by an HIV specialist or infectious disease physician.

How It Works

HIV has to fuse its outer coat with a CD4 immune cell before it can get inside. A viral protein called gp41 drives that fusion. This medicine is a short chain of 34 amino acids carrying a small chemical add-on that latches on to albumin, the most common protein in blood. Once bound, the peptide blocks gp41 and stops the virus at the very first step of infection. The albumin link keeps it in the body far longer than an ordinary peptide, which is why one dose a week is enough.

What the Trial Showed

The phase 3 TALENT study, run at 12 hospitals in China, enrolled adults whose first-line HIV treatment had stopped working (viral load above 1,000 copies/mL after more than six months). One group took the new weekly infusion plus a boosted protease inhibitor; the other took a standard comparison regimen. In the interim analysis published in the Chinese Medical Journal (2020), 80.4% of people on the infusion-based regimen had an undetectable viral load (below 50 copies/mL) at week 48, against 66.0% in the comparison group. Among people who followed the protocol fully, the figures were 94.9% and 74.4%. The new regimen met the non-inferiority goal.

Recommended Dosage

The TALENT trial used this schedule:

  • Loading: 320 mg by intravenous infusion once a day for the first three days
  • Maintenance: 320 mg by intravenous infusion once a week after that
  • Taken alongside other HIV medicines chosen by the treating doctor

Each vial contains 160 mg, so one 320 mg dose uses two vials. The infusion is given in a clinic or hospital. Your HIV specialist will confirm the exact dose and the medicines it is combined with.

This information is not a treatment plan. For personalized medical advice, consult your doctor and refer to the full prescribing information.

Warnings and Precautions

Overall safety: in the TALENT interim safety analysis (93 people on the new regimen, 99 on the comparison regimen), severe (grade 3–4) side effects were reported at similar rates: 14.0% and 11.1% respectively.

  • Stomach upset: diarrhoea was the most common complaint, seen in 8.6% of people on this medicine compared with 14.1% of the comparison group.
  • Blood fats: a marked rise in triglycerides (grade 3–4) occurred in 6.5% versus 4.0%. Your doctor may check fasting lipids during treatment.
  • Headache: reported by 2.2% of treated patients, against none in the comparison group.
  • Kidneys: kidney function (eGFR) fell less on this regimen than in the comparison group at week 12 (−1.22 vs −11.48 mL/min/1.73 m²). Kidney tests are still part of routine HIV care.
  • Infusion visits: because it is given into a vein, every dose needs a clinic visit. Report any rash, breathlessness, fever or swelling during or after the drip.

Staying on schedule: missing weekly doses can let the virus grow back and become resistant to treatment. The trial authors stress close follow-up for this reason. The study enrolled adults only; discuss pregnancy, breastfeeding or use in children with your specialist before starting.

How to Access Albuvirtide in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant, cold-chain conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Albuvirtide to India?

This injection can be brought in only for a named patient, by the patient or a government hospital, under the rules for importing unapproved medicines into India. Please keep ready:

  • A prescription from an HIV specialist or infectious disease physician
  • Recent viral load, CD4 count and, if available, resistance test reports, with details of earlier HIV treatment
  • Patient ID proof (issued by the Government of India)

How is the order confirmed?

After our team has checked the prescription and medical reports, and an import permit is in place where one is required.

Is Albuvirtide available in India?

No. It is approved in China only. CDSCO has not approved it, Indian pharmacies do not stock it, and it has no US FDA approval.

A doctor can still request it for one specific patient through the Named Patient Program route, which allows legal, prescription-based import of a medicine that is not registered in India.

It can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.

Sourcing & Delivery

NamedPatientProgram.com (NPP) sources this medicine through the manufacturer's authorised supply channels in China and arranges supply to patients, doctors, and hospitals under applicable legal provisions. The Chinese pack states that the vials must be kept sealed, away from light, in a refrigerator at 2°C to 8°C, so every shipment moves under cold-chain shipping to the treating clinic. Since a weekly dose uses two vials, we plan supply in blocks of several weeks so treatment is not interrupted. All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.

For the current cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.

Availability Across Major Cities in India

People living with HIV across India can access this medicine through a regulated import route, with refrigerated delivery to the clinic that gives the weekly infusion, on a valid specialist's prescription.

Delhi

Large infectious disease departments in the capital can receive weekly supplies quickly from our New Delhi dispatch point.

Mumbai

The refrigerated vials go directly to the clinic where the weekly infusion is given.

Bangalore

An HIV specialist in Bangalore can send the prescription and viral load reports to start a named-patient request.

Chennai

Clinics in Chennai can plan several weeks of stock in one shipment to match the dosing calendar.

Hyderabad

Deliveries are timed so the clinic has vials ready before each scheduled infusion day.

Kolkata

Cold-chain packaging keeps the vials between 2°C and 8°C on the journey to eastern India.

Pune

Patients and doctors in Pune receive a written quote and timeline before any order is placed.

Ahmedabad

The treating physician shares the treatment history, and we handle the import paperwork from there.

Vellore

Supplies can be sent to the hospital pharmacy that gives the weekly drip.

Chandigarh

Covers patients from Punjab, Haryana and Himachal Pradesh, with delivery to the treating centre.

Lucknow

We arrange refrigerated delivery to hospitals across Uttar Pradesh that manage HIV care.

Kochi

Patients in Kerala can have the vials delivered to their clinic in Kochi or a nearby city.

Access can also be coordinated for patients in other Indian cities, subject to a valid prescription and regulatory requirements.

Author Details

Nitin Goswami

Written By

Nitin Goswami

Deputy Manager – Content & Social Media, Ikris Pharma Network

Sources: NMPA • CDSCO

Dr. Chirag C Shah

Medically Reviewed By

Dr. Chirag C Shah

MBBS

Last Updated: 18 November 2026

More Other Therapeutic Areas Medicines

TRUSTED BY HEALTHCARE PROFESSIONALS & HOSPITALS

Need Help
Accessing Medicines?

Our specialists are here to guide you through every step of the medicine access process.

Let's us help!

Send us a message

Read how to access medicines

Read More arrow icon

Frequently Asked
Questions

Read More
Meet the NPP Assistant: ask us anything about NPP